Platelet and red blood cell (RBC) transfusion requirements of nonmyeloablative (NM) HLA-matched related and unrelated donor hematopoietic cell transplantation (HCT): Influence of genetic disparity and ABO-incompatibility.

被引:0
|
作者
Wang, Zejing
Schoch, Gary
Leisenring, Wendy M.
Sandmaier, Brenda M.
Maloney, David G.
Storb, Rainer F.
机构
[1] FHCRC, Seattle, WA USA
[2] FHCRC, Clin Stat Program, Seattle, WA USA
[3] UW, Seattle, WA USA
关键词
D O I
10.1182/blood.V108.11.2985.2985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2985
引用
收藏
页码:846A / 846A
页数:1
相关论文
共 50 条
  • [21] Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor
    Sugita, Junichi
    Kuroha, Takashi
    Ishikawa, Jun
    Eto, Tetsuya
    Fukushima, Kentaro
    Yokota, Isao
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 344 - 349
  • [22] Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation
    Wegener, Alma
    Andersen, Niels Smedegaard
    Friis, Lone Smidstrup
    Petersen, Soren Lykke
    Schjodt, Ida
    Kornblit, Brian
    Sengelov, Henrik
    Gjaerde, Lars Klingen
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 575e1 - 575e6
  • [23] Transfusion Support in the First 30 and 100 Days after Haploidentical versus HLA-matched Related Donor Hematopoietic Stem Cell Transplantation
    Santos Gomez, Mireia
    Ancochea Serra, Agueda
    Alonso Nogues, Eva
    Grifols Ronda, Joan Ramon
    Morgades de la Fe, Mireia
    Franch Sarto, Mireia
    Gener Ricos, Georgina
    Ferra Coll, Christelle
    Vives Polo, Susana
    Torrent Catarineu, Anna
    Moreno Velazquez, Miriam
    Batlle Massana, Montserrat
    Xicoy Cirici, Blanca
    Abril Sabater, Laura
    Ibarra Fernandez, Gladys
    Senin Magan, Alicia
    Oriol Rocafiguera, Albert
    Ribera Santasusana, Josep Maria
    Sancho Cia, Juan Manuel
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 428 - 428
  • [24] Incidence of severe delayed immunehemolysis after minor ABO-incompatible, HLA-matched, related and unrelated donor, non-myeloablative hematopoietic stem cell transplantation.
    Mielcarek, M
    Zaucha, JM
    Sandmaier, B
    Maloney, D
    Maris, M
    Feinstein, L
    Torok-Storb, B
    Storb, R
    BLOOD, 2001, 98 (11) : 778A - 778A
  • [25] Sequential Autologous Followed by Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors Improves Outcomes of Patients (pts) with Bulky Lymphoma or Chronic Lymphocytic Leukemia (CLL)
    Sorror, Mohamed L.
    Storer, Bany
    Sandmaier, Brenda M.
    Chauncey, Thomas
    Maris, Michael T.
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2010, 116 (21) : 979 - 979
  • [26] HLA-matched related (MRD) or unrelated donor (URD) non-myeloablative hematopoietic cell transplantation (HCT) for patients (pts) with refractory and relapsed aggressive non Hodgkin lymphoma (NHL).
    Norasetthada, L
    Maris, MB
    Sandmaier, BM
    Gooley, T
    Forman, S
    Agura, E
    Maziarz, RT
    Shizuru, J
    Niederwieser, D
    Storb, R
    Maloney, DG
    BLOOD, 2004, 104 (11) : 634A - 635A
  • [27] HLA-matched related (MRD) or unrelated donor (URD) non-myeloablative conditioning and hematopoietic cell transplant (HCT) for patients with advanced Hodgkin disease (HD)
    Burroughs, LM
    Maris, MB
    Sandmaier, BM
    Leisenring, W
    Stuart, MJ
    Niederwieser, D
    McSweeney, PA
    Chauncey, T
    Maziarz, R
    Agura, E
    Little, MT
    Blume, KG
    Storb, R
    Maloney, DG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 73 - 74
  • [28] Red Blood Cell (RBC) Transfusion Requirements During Matched Sibling Donor Bone Marrow Transplantation for Sickle Cell Disease Are Lower in Patients Who Receive Extended RBC Phenotype Matching
    McPherson, M.
    Haight, A. E.
    Jessup, P.
    Castillejo, M.
    Josephson, C.
    TRANSFUSION, 2011, 51 : 113A - 113A
  • [29] Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors.
    Sorror, Mohamed L.
    Storer, Barry
    Sandmaier, Brenda M.
    Franke, Georg N.
    Laport, Ginna G.
    Chauncey, Thomas
    Agura, Edward
    Maris, Michael T.
    Wade, James
    Pulsipher, Michael A.
    Maziarz, Richard T.
    Sahebi, Firoozeh
    McSweeney, Peter
    Bruno, Benedetto
    Vindelov, Lars
    Yeager, Andrew M.
    Rezvani, Andrew
    Niederwieser, Dietger W.
    Blume, Karl G.
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2010, 116 (21) : 553 - 553
  • [30] Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)
    AlDawsari, Ghuzayel
    Elhaddad, Alaa
    El Fakih, Riad
    Ben Othman, Tarek
    Ahmed, Parvez
    Ghavamzadeh, Ardeshir
    Bazarbachi, Ali
    Dasouki, Majed J.
    Fathy, Gamal
    Alzahrani, Hazzaa
    Samra, Mohamed
    Torjemane, Lamia
    Satti, Tariq Mahmood
    Shaheen, Marwan
    Alfraih, Feras
    Ayas, Mouhab
    Alahmari, Ali
    Alhayli, Saud
    Nassar, Amr
    Abboud, Miguel
    Abdelfattah, Raafat
    El Solh, Hassan
    Hashmi, Shahrukh
    Elhassan, Tusneem
    Ahmed, Syed Osman
    Aljurf, Mahmoud
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1485 - 1490